DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Astonea Labs Ltd (ASTONEALAB) share price today?

Astonea Labs Ltd (ASTONEALAB) is trading at ₹272.45 on the BSE, down 2.00% on the day. Source: DocStoX.

What is the PE ratio of Astonea Labs Ltd?

Astonea Labs Ltd has a price-to-earnings (PE) ratio of 39.3 in the Healthcare sector.

What is the market capitalisation of Astonea Labs Ltd?

Astonea Labs Ltd has a market capitalisation of approximately ₹292 crore.

Astonea Labs Ltd

ASTONEALAB·BSE·Healthcare

₹272.45▼ -5.55 (-2.00%)

Healthcare · Pharmaceuticals & Biotechnology

A steady, established business

52W₹118

₹30184%

Open

₹272.45

High

₹272.45

Low

₹272.45

Prev Close

₹278.00

Volume

1.0K

VWAP

₹272.45

Snapshot

Key fundamentals

Market Cap

₹292 Cr

P/E Ratio

39.31Expensive

P/B Ratio

5.11

EPS

₹6.93

Book Value

₹54.35

ROE

12.00%Average

ROCE

17.00%Decent

Dividend Yield

0.00%

Debt / Equity

0.74Moderate

Face Value

₹10.00

52W High

₹301.30

52W Low

₹118.00

Sector

Healthcare

Industry

Pharmaceuticals & Biotechnology

Avoid

Narrow moatMedium uncertainty

Fair value estimate

₹102

▼ 62.6%downside

Trading at ₹272 — 63% above our estimate

BearFair valueBull

₹73₹102₹117

/100

Business quality — Watch the fundamentals

Growth 50Profitability 26Efficiency 45Valuation 45

Plain English

Our view

A steady, established business
Promoters hold a controlling stake

How we got there

Fair value methods

Residual income

29% ROE fading to 13% over ~10 yrs, on ₹54 book

₹110

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹73

Analyst target

No analyst coverage

—

Blended fair value₹102

What the numbers say

Investment thesis

Bull case

Promoters hold a controlling stake

Bear case

No notable red flags from the current metrics.

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

39.3Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

12.0%Average

Above 15% is considered healthy for Indian equities

ROCE

17.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.74Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹292 Cr

P/B

5.11

EPS

₹6.93

Div Yield

—

What changed

Recent changes

Foreign investors-2.5% stake last quarter
Domestic institutions-0.3% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 39.3×

Growth

Strong

+30% rev CAGR

Profitability

Healthy

12.0% ROE

Financial health

Comfortable

D/E 0.74

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹2.72L Cr

Trades1

VWAP₹272.45

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+30.1%

—

10Y

—

Profit

+57.8%

—

10Y

—

EPS

+36.8%

—

10Y

—

Profile

Cons

Stock is trading at 5.11 times its book value
Though the company is reporting repeated profits, it is not paying out dividend
Company might be capitalizing the interest cost
Working capital days have increased from 43.9 days to 74.2 days

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Foreign investors sold 2.51 pts; domestic institutions reduced 0.28 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

72%

Promoter

Promoters

72.3%0.00

Public

22.3%+5.19

FII / FPI

0.0%-2.51

DII

0.1%-0.28

Others

5.4%

Total shareholders

376-61 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter72.30%

DII0.07%

Public22.25%

Others5.38%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 2017, Astonea Labs Ltd. is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies[1]

Astonea Labs Ltd valuation & research

Deep-dive tools with DocStoX's fair-value estimate, ratios and peers.

Fair Value Intrinsic Value DCF Valuation Financial Ratios Peers

Astonea Labs Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Ltd Divis Laboratories Ltd Torrent Pharmaceuticals Ltd Apollo Hospitals Enterprise Ltd Zydus Lifesciences Ltd Cipla Ltd Lupin Ltd Max Healthcare Institute Ltd Mankind Pharma Ltd Dr Reddys Laboratories Ltd Aurobindo Pharma Ltd Laurus Labs Ltd

Compare Astonea Labs Ltd with peers

Astonea Labs Ltd vs Sun Pharmaceutical Industries Ltd Astonea Labs Ltd vs Divis Laboratories Ltd Astonea Labs Ltd vs Torrent Pharmaceuticals Ltd Astonea Labs Ltd vs Apollo Hospitals Enterprise Ltd Astonea Labs Ltd vs Zydus Lifesciences Ltd Astonea Labs Ltd vs Cipla Ltd

Related tools & concepts

Value Astonea Labs Ltd with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Astonea Labs Ltd

Key fundamentals

Key statistics

Recent changes

News impact

Overview

Trading activity

Technical signals

Growth (CAGR)

Company information

Cons

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership breakdown

Ownership over time

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Frequently asked questions

Astonea Labs Ltd valuation & research

Astonea Labs Ltd peers in Healthcare

Compare Astonea Labs Ltd with peers

Related tools & concepts

Key statistics

Recent changes

News impact

Trading activity

Technical signals

Growth (CAGR)

Company information

Cons

Ownership breakdown

Ownership over time

Frequently asked questions